Pharvaris PHVS
NASDAQ PHVS
$35.25 -0.41 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Long-Term Deferred Tax (2020 - 2026)

Pharvaris' (PHVS) quarterly Long-Term Deferred Tax came in at $875169.8 in Q1 2026, up 123.46% YoY from $391638.7 in Q1 2025, and down 15.27% on a QoQ basis from $1.0 million in Q4 2025.

Analysis

Pharvaris (PHVS) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends

Pharvaris (PHVS) has 7 years of Long-Term Deferred Tax data on file, last reported at $875169.8 in Q1 2026.

  • Quarterly Long-Term Deferred Tax rose 123.46% year-over-year to $875169.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $875169.8 (up 123.46% YoY) and the FY2025 annual result came in at $1.0 million, up 95.27% from the prior year.
  • Long-Term Deferred Tax declined to $875169.8 in Q1 2026, from $1.0 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $1.0 million in Q4 2025 to a low of $96667.3 in Q1 2023.
  • A 5-year average of $385868.2 and a median of $337180.2 in 2025 frame the typical range for Long-Term Deferred Tax.
  • Annual changes were most pronounced in 2023 — Long-Term Deferred Tax tumbled 36.97% — and 2024, when it soared 345.14%.
  • Tracing PHVS's Long-Term Deferred Tax over 5 years: stood at $265063.3 in 2022, then jumped by 57.31% to $416957.9 in 2023, then increased by 21.57% to $506885.0 in 2024, then jumped by 103.78% to $1.0 million in 2025, then declined by 15.27% to $875169.8 in 2026.
  • The last three Long-Term Deferred Tax figures came in at $875169.8 (Q1 2026), $1.0 million (Q4 2025), and $535260.1 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Pharvaris 2.10 Bn 1.73 Bn 85,072.10
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 673.14 Bn
Mar 31, 2026 875.17 Bn
Dec 31, 2025 1,032.92 Bn
Sep 30, 2025 535,260.06
Jun 30, 2025 337,180.23
Mar 31, 2025 391,638.67
Dec 31, 2024 506.89 Bn
Sep 30, 2024 267,827.18
Jun 30, 2024 373,271.85
Mar 31, 2024 430,304.64
Dec 31, 2023 416.96 Bn
Sep 30, 2023 329,461.91
Jun 30, 2023 199.83 Bn
Mar 31, 2023 96,667.31
Dec 31, 2022 265.06 Bn
Sep 30, 2022 241,413.14
Jun 30, 2022 106,547.74
Mar 31, 2022 153,362.96
Dec 31, 2021 196.82 Bn
Sep 30, 2021 138,139.36